Literature DB >> 22687180

Emergency department case volume and patient outcomes in acute exacerbations of chronic obstructive pulmonary disease.

Chu-Lin Tsai1, George L Delclos, Carlos A Camargo.   

Abstract

OBJECTIVES: The objective was to determine whether emergency department (ED) case volume of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is associated with patient outcomes in AECOPD.
METHODS: The authors analyzed the 2007 Nationwide Emergency Department Sample (NEDS), the largest publicly available all-payer ED database in the United States. ED visits for AECOPD were identified with a principal diagnosis of International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code 491.21. EDs were categorized into quartiles by ED case volume of AECOPD. The primary outcome measures were early inpatient mortality (within the first 3 days of admission) and hospital length of stay (LOS).
RESULTS: The 2007 NEDS sample contained 126,045 ED visits for AECOPD from 946 U.S. EDs; 58% were hospitalized. Of these, the overall inpatient mortality rate was 2.0%, the early inpatient mortality 0.6%, and the median hospital LOS 4 days. Early inpatient mortality was lower in the highest-volume EDs (0.47%), compared with the lowest-volume EDs (1.13%). In a multivariable analysis adjusting for 37 patient and hospital characteristics, early inpatient mortality remained lower in patients admitted through the highest-volume EDs (adjusted odds ratios [ORs] = 0.51; 95% confidence interval [CI] = 0.32 to 0.82), compared with the lowest-volume EDs; however, the hospital LOS in the highest-volume EDs was slightly longer (adjusted difference in LOS = 0.53 day; 95% CI = 0.29 to 0.77). The volume threshold for reduced early mortality was approximately 200 cases per year.
CONCLUSIONS: ED patients who are hospitalized for AECOPD have an approximately 50% reduction in early inpatient mortality if they were admitted from an ED that handles a large volume of AECOPD cases.
© 2012 by the Society for Academic Emergency Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 22687180     DOI: 10.1111/j.1553-2712.2012.01363.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  6 in total

1.  Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease Exacerbation.

Authors:  Liza Genao; Michael T Durheim; Xiaojuan Mi; Jamie L Todd; Heather E Whitson; Lesley H Curtis
Journal:  Ann Am Thorac Soc       Date:  2015-12

2.  Who provides what care? An analysis of clinical focus among the national emergency care workforce.

Authors:  Cameron J Gettel; Maureen E Canavan; Gail D'Onofrio; Brendan G Carr; Arjun K Venkatesh
Journal:  Am J Emerg Med       Date:  2020-12-03       Impact factor: 2.469

3.  Impact of emergency care centralisation on mortality and efficiency: a retrospective service evaluation.

Authors:  Christopher Price; Stephen McCarthy; Angela Bate; Peter McMeekin
Journal:  Emerg Med J       Date:  2020-01-07       Impact factor: 2.740

4.  Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS).

Authors:  Jasvinder A Singh; Shaohua Yu
Journal:  Respir Res       Date:  2016-01-06

5.  Time trends in coronary revascularization procedures among people with COPD: analysis of the Spanish national hospital discharge data (2001-2011).

Authors:  Javier de Miguel-Díez; Rodrigo Jiménez-García; Valentín Hernández-Barrera; Pilar Carrasco-Garrido; Héctor Bueno; Luis Puente-Maestu; Isabel Jimenez-Trujillo; Alejandro Alvaro-Meca; Jesús Esteban-Hernandez; Ana López de Andrés
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-10-22

6.  Hospital volume and mortality for 25 types of inpatient treatment in German hospitals: observational study using complete national data from 2009 to 2014.

Authors:  Ulrike Nimptsch; Thomas Mansky
Journal:  BMJ Open       Date:  2017-09-06       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.